New Research Questions routine Contrast use in Prostate Cancer MRI
CHICAGO – Current standard practice for MRI scans used to diagnose prostate cancer may be unnecessarily exposing patients to potential risks associated with contrast agents, according to recent findings highlighted in the JAMA Network™. A growing body of research suggests that, in many cases, skipping the contrast agent doesn’t significantly impact diagnostic accuracy.
The JAMA Network™, a resource for the medical community published by the american Medical Association (AMA), recently featured studies with implications for prostate cancer diagnosis. While not directly addressing the contrast question, the network’s coverage underscores the importance of continually evaluating diagnostic procedures.
The JAMA Network emphasizes the benefits of membership, including full access to journals like JAMA, JAMA Network Open, and JAMA Psychiatry, offering resources like full-text PDFs, clinical challenges, and author interviews. These resources can help physicians stay abreast of evolving best practices.
Recent research published in JAMA network Open focused on disparities in pediatric cardiac arrest survival, finding higher mortality rates among children from historically marginalized racial and ethnic groups. Another study in JAMA Psychiatry investigated the impact of high-intensity exercise on individuals with cannabis use disorder, finding it didn’t improve hippocampal integrity but did potentially reduce cannabis craving.
The JAMA Network also provides physicians with opportunities to earn AMA PRA Category 1 Credit™ through CME courses and fulfill maintenance of licensure requirements via JN Learning™.Resources include concise summaries of clinical guidelines and patient-friendly articles.
For more facts on accessing these educational materials and innovative tools, AMA members and those interested in joining can visit https://www.ama-assn.org/member-benefits/personal-member-benefits-discounts/jama-network-member-benefits.
